Skip to main content
SpringerLink
Log in

Aminocaproic acid/bevacizumab/tranexamic acid

Lack of efficacy in hereditary haemorrhagic telangiectasia and off label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Masood M, et al. Management of refractory gastrointestinal bleeding in hereditary hemorrhagic telangiectasia with bevacizumab. American Journal of Gastroenterology 115 (Suppl.): S1174 abstr. S2218, Oct 2020. Available from: URL: http://doi.org/10.14309/01.ajg.0000710920.18899.a2 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aminocaproic acid/bevacizumab/tranexamic acid. Reactions Weekly 1836, 47 (2021). https://doi.org/10.1007/s40278-021-87866-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-87866-z

Search

Navigation